Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shares of NYSE:MPLX opened at $53.89 on Friday. The firm has a market cap of $54.90 billion, a P/E ratio of 12.80, a P/E/G ratio of 1.69 and a beta of 1.42. The company has a quick ratio of 0.95 ...
Federal employees at multiple government agencies are once again being told to report their work accomplishments over the past week to the Trump administration, according to a union source and ...
(RTTNews) - MPLX LP (MPLX), a large-cap master limited partnership, announced Friday that it has signed a definitive agreement with affiliates of WhiteWater and Diamondback Energy to buy the ...
MPLX (NYSE:MPLX) said Friday it agreed to acquire the remaining 55% interest in the BANGL pipeline system in Texas from affiliates of WhiteWater and Diamondback Energy (FANG) for $715M; upon ...
FINDLAY, Ohio, Feb. 28, 2025 /PRNewswire/ -- MPLX LP (NYSE: MPLX ) today announced it has signed a definitive agreement with affiliates of WhiteWater and Diamondback energy to acquire the ...
These seven high-quality ETFs provide current income and offer the opportunity for growth over time.
FINDLAY, Ohio, Feb. 27, 2025 /PRNewswire/ -- MPLX LP (NYSE: MPLX) today filed with the U.S. Securities and Exchange Commission its Annual Report on Form 10-K for the year ended Dec. 31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results